Last reviewed · How we verify

NCT06194773

The Effect of Totalfil and Neosealer Sealers on the Post-endodontic Pain

Completed NA Last updated 18 March 2025
What this trial tests

NA trial testing Totalfil in Irreversible Pulpitis in 39 participants. Completed in 6 January 2025.

Timeline
26 June 2023
Primary endpoint
6 December 2024
6 January 2025

Quick facts

Lead sponsorGulf Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment39
Start date26 June 2023
Primary completion6 December 2024
Estimated completion6 January 2025
Sites1 location across United Arab Emirates

Drugs / interventions tested

Conditions studied

Sponsor

Gulf Medical University

Who can join

Adults 18 to 70, any sex, with Irreversible Pulpitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the effect of Totalfil and Neosealer sealers on post-endodontic pain compared to AH plus sealer in mandibular molars with symptomatic irreversible pulpitis. The main question: do Totalfil and Neosealer sealers affect postoperative pain intensity after root canal treatment in mandibular molars with symptomatic irreversible pulpitis? Participants will undergo root canal treatment using totalfil, Neosealer, or AH-Plus sealer. Researchers will compare Totalfil, Neosealer, and AH-Plus to assess the intensity of post-endodontic pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Irreversible Pulpitis

Currently open trials in the same condition.

Other Gulf Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06194773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing